The earlier, the better: The beneficial effect of different timepoints of the preoperative transarterial embolization on ameliorating operative blood loss and operative time for carotid body tumors
To explore the effect of the optimal time interval from preoperative transarterial embolization to surgery of carotid body tumors by analyzing surgery-related indicators. This single-center retrospective review included 103 patients and 108 carotid body tumor resections performed between June 2010 a...
Gespeichert in:
| Veröffentlicht in: | Surgery 2021-11, Vol.170 (5), p.1581-1585 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1585 |
|---|---|
| container_issue | 5 |
| container_start_page | 1581 |
| container_title | Surgery |
| container_volume | 170 |
| creator | Li, Nan Zeng, Ni Wan, Yuan Wen, Chunyong Yang, Jianyong Li, Jiaping Dai, Haitao Liao, Changli Tang, Keyu Wang, Jingsong Chang, Guangqi Huang, Yonghui |
| description | To explore the effect of the optimal time interval from preoperative transarterial embolization to surgery of carotid body tumors by analyzing surgery-related indicators.
This single-center retrospective review included 103 patients and 108 carotid body tumor resections performed between June 2010 and June 2020. All carotid body tumors were divided into three groups based on interval time between transarterial embolization and surgery: 1-day group (G1), 2-day group (G2), and 3-day group (G3). Demographics, inflammatory biomarkers, periprocedural details, and postoperative outcomes were analyzed.
Among 103 patients, 48.54% were women, and the mean age was 37.07 years. The tumor sizes were 43.83, 44.31, and 42.84 mm in G1, G2, and G3, respectively, and the blood loss and operative time were 163.68, 331.54, and 683.68 mL, and 182.32, 216.31, and 280.79 mins with the prolonged time interval, respectively. Compared with pretransarterial embolization, the expression of white blood cells (109/L) and neutrophils (109/L) were obviously increased post-transarterial embolization in the three groups (G1: white blood cells 6.81 vs 9.32; neutrophils 0.54 vs 0.74, all P < .05. G2: white blood cells 7.19 vs 10.01, P = .118; neutrophils 0.54 vs 0.77, P < .05. G3: white blood cells 7.08 v. 12.37; neutrophils 0.59 vs 0.80, all P < .05), and those in G3 were significantly higher than those in G1. The incidences of revascularization, which was 30.26%, 53.85%, and 42.10%, and adverse events (26.32%, 30.77%, and 21.05%) were not significantly different among G1, G2, and G3.
The optimal time interval between preoperative transarterial embolization and surgical resection resulted as 1 day as patients in this group showed obvious lower blood loss and shorter duration of operation than patients in other groups. Both inflammation and recanalization provided support for these results at some extent. |
| doi_str_mv | 10.1016/j.surg.2021.07.005 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2560297467</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0039606021006887</els_id><sourcerecordid>2560297467</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-e6aa824fc708535f678c49308c5e65f4218689b0585fd475a89404cc86a5de833</originalsourceid><addsrcrecordid>eNp9kc1u1TAQhS0EopfCC7BAXrIgYRLHjoPYoAoKUiU2l7Xl2OPiqyS-2E6l9v14L5ze8rNCsuQZzznHGn2EvGygbqARbw91WuN13ULb1NDXAPwR2TWctVXPRPOY7ADYUAkQcEaepXQAgKFr5FNyxjrWCwZiR37uvyNFHSeP8Q3NpRkxZ4zv6P6-XtB54_VE0Tk0mQZHrS9lxCXT7Gc8Br_ktL1v5mPEcMSos79BmqNeko4l7T5gHsPk78ooLLQcPePkwyZdrulf0ziFYOkUUqJ6sf8Mts-oC5EaHUP2lo7B3tK8ziGm5-SJ01PCFw_3Ofn26eP-4nN19fXyy8WHq8owLnKFQmvZds70IDnjTvTSdAMDaTgK7rq2kUIOI3DJne16ruXQQWeMFJpblIydk9en3GMMP1ZMWc0-GZwmvWBYk2q5gHboO9EXaXuSmlh2iejUMfpZx1vVgNrwqYPa8KkNn4JeFXzF9Oohfx1ntH8sv3kVwfuTAMuWN4WZSsbjYtD6WPAoG_z_8n8BawWw2w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2560297467</pqid></control><display><type>article</type><title>The earlier, the better: The beneficial effect of different timepoints of the preoperative transarterial embolization on ameliorating operative blood loss and operative time for carotid body tumors</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Li, Nan ; Zeng, Ni ; Wan, Yuan ; Wen, Chunyong ; Yang, Jianyong ; Li, Jiaping ; Dai, Haitao ; Liao, Changli ; Tang, Keyu ; Wang, Jingsong ; Chang, Guangqi ; Huang, Yonghui</creator><creatorcontrib>Li, Nan ; Zeng, Ni ; Wan, Yuan ; Wen, Chunyong ; Yang, Jianyong ; Li, Jiaping ; Dai, Haitao ; Liao, Changli ; Tang, Keyu ; Wang, Jingsong ; Chang, Guangqi ; Huang, Yonghui</creatorcontrib><description>To explore the effect of the optimal time interval from preoperative transarterial embolization to surgery of carotid body tumors by analyzing surgery-related indicators.
This single-center retrospective review included 103 patients and 108 carotid body tumor resections performed between June 2010 and June 2020. All carotid body tumors were divided into three groups based on interval time between transarterial embolization and surgery: 1-day group (G1), 2-day group (G2), and 3-day group (G3). Demographics, inflammatory biomarkers, periprocedural details, and postoperative outcomes were analyzed.
Among 103 patients, 48.54% were women, and the mean age was 37.07 years. The tumor sizes were 43.83, 44.31, and 42.84 mm in G1, G2, and G3, respectively, and the blood loss and operative time were 163.68, 331.54, and 683.68 mL, and 182.32, 216.31, and 280.79 mins with the prolonged time interval, respectively. Compared with pretransarterial embolization, the expression of white blood cells (109/L) and neutrophils (109/L) were obviously increased post-transarterial embolization in the three groups (G1: white blood cells 6.81 vs 9.32; neutrophils 0.54 vs 0.74, all P < .05. G2: white blood cells 7.19 vs 10.01, P = .118; neutrophils 0.54 vs 0.77, P < .05. G3: white blood cells 7.08 v. 12.37; neutrophils 0.59 vs 0.80, all P < .05), and those in G3 were significantly higher than those in G1. The incidences of revascularization, which was 30.26%, 53.85%, and 42.10%, and adverse events (26.32%, 30.77%, and 21.05%) were not significantly different among G1, G2, and G3.
The optimal time interval between preoperative transarterial embolization and surgical resection resulted as 1 day as patients in this group showed obvious lower blood loss and shorter duration of operation than patients in other groups. Both inflammation and recanalization provided support for these results at some extent.</description><identifier>ISSN: 0039-6060</identifier><identifier>EISSN: 1532-7361</identifier><identifier>DOI: 10.1016/j.surg.2021.07.005</identifier><identifier>PMID: 34376306</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adolescent ; Adult ; Blood Loss, Surgical - prevention & control ; Carotid Body Tumor - surgery ; Child ; Embolization, Therapeutic ; Female ; Humans ; Male ; Middle Aged ; Operative Time ; Preoperative Care ; Retrospective Studies ; Time Factors ; Young Adult</subject><ispartof>Surgery, 2021-11, Vol.170 (5), p.1581-1585</ispartof><rights>2021 Elsevier Inc.</rights><rights>Copyright © 2021 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-e6aa824fc708535f678c49308c5e65f4218689b0585fd475a89404cc86a5de833</citedby><cites>FETCH-LOGICAL-c356t-e6aa824fc708535f678c49308c5e65f4218689b0585fd475a89404cc86a5de833</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0039606021006887$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34376306$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Nan</creatorcontrib><creatorcontrib>Zeng, Ni</creatorcontrib><creatorcontrib>Wan, Yuan</creatorcontrib><creatorcontrib>Wen, Chunyong</creatorcontrib><creatorcontrib>Yang, Jianyong</creatorcontrib><creatorcontrib>Li, Jiaping</creatorcontrib><creatorcontrib>Dai, Haitao</creatorcontrib><creatorcontrib>Liao, Changli</creatorcontrib><creatorcontrib>Tang, Keyu</creatorcontrib><creatorcontrib>Wang, Jingsong</creatorcontrib><creatorcontrib>Chang, Guangqi</creatorcontrib><creatorcontrib>Huang, Yonghui</creatorcontrib><title>The earlier, the better: The beneficial effect of different timepoints of the preoperative transarterial embolization on ameliorating operative blood loss and operative time for carotid body tumors</title><title>Surgery</title><addtitle>Surgery</addtitle><description>To explore the effect of the optimal time interval from preoperative transarterial embolization to surgery of carotid body tumors by analyzing surgery-related indicators.
This single-center retrospective review included 103 patients and 108 carotid body tumor resections performed between June 2010 and June 2020. All carotid body tumors were divided into three groups based on interval time between transarterial embolization and surgery: 1-day group (G1), 2-day group (G2), and 3-day group (G3). Demographics, inflammatory biomarkers, periprocedural details, and postoperative outcomes were analyzed.
Among 103 patients, 48.54% were women, and the mean age was 37.07 years. The tumor sizes were 43.83, 44.31, and 42.84 mm in G1, G2, and G3, respectively, and the blood loss and operative time were 163.68, 331.54, and 683.68 mL, and 182.32, 216.31, and 280.79 mins with the prolonged time interval, respectively. Compared with pretransarterial embolization, the expression of white blood cells (109/L) and neutrophils (109/L) were obviously increased post-transarterial embolization in the three groups (G1: white blood cells 6.81 vs 9.32; neutrophils 0.54 vs 0.74, all P < .05. G2: white blood cells 7.19 vs 10.01, P = .118; neutrophils 0.54 vs 0.77, P < .05. G3: white blood cells 7.08 v. 12.37; neutrophils 0.59 vs 0.80, all P < .05), and those in G3 were significantly higher than those in G1. The incidences of revascularization, which was 30.26%, 53.85%, and 42.10%, and adverse events (26.32%, 30.77%, and 21.05%) were not significantly different among G1, G2, and G3.
The optimal time interval between preoperative transarterial embolization and surgical resection resulted as 1 day as patients in this group showed obvious lower blood loss and shorter duration of operation than patients in other groups. Both inflammation and recanalization provided support for these results at some extent.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Blood Loss, Surgical - prevention & control</subject><subject>Carotid Body Tumor - surgery</subject><subject>Child</subject><subject>Embolization, Therapeutic</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Operative Time</subject><subject>Preoperative Care</subject><subject>Retrospective Studies</subject><subject>Time Factors</subject><subject>Young Adult</subject><issn>0039-6060</issn><issn>1532-7361</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1u1TAQhS0EopfCC7BAXrIgYRLHjoPYoAoKUiU2l7Xl2OPiqyS-2E6l9v14L5ze8rNCsuQZzznHGn2EvGygbqARbw91WuN13ULb1NDXAPwR2TWctVXPRPOY7ADYUAkQcEaepXQAgKFr5FNyxjrWCwZiR37uvyNFHSeP8Q3NpRkxZ4zv6P6-XtB54_VE0Tk0mQZHrS9lxCXT7Gc8Br_ktL1v5mPEcMSos79BmqNeko4l7T5gHsPk78ooLLQcPePkwyZdrulf0ziFYOkUUqJ6sf8Mts-oC5EaHUP2lo7B3tK8ziGm5-SJ01PCFw_3Ofn26eP-4nN19fXyy8WHq8owLnKFQmvZds70IDnjTvTSdAMDaTgK7rq2kUIOI3DJne16ruXQQWeMFJpblIydk9en3GMMP1ZMWc0-GZwmvWBYk2q5gHboO9EXaXuSmlh2iejUMfpZx1vVgNrwqYPa8KkNn4JeFXzF9Oohfx1ntH8sv3kVwfuTAMuWN4WZSsbjYtD6WPAoG_z_8n8BawWw2w</recordid><startdate>202111</startdate><enddate>202111</enddate><creator>Li, Nan</creator><creator>Zeng, Ni</creator><creator>Wan, Yuan</creator><creator>Wen, Chunyong</creator><creator>Yang, Jianyong</creator><creator>Li, Jiaping</creator><creator>Dai, Haitao</creator><creator>Liao, Changli</creator><creator>Tang, Keyu</creator><creator>Wang, Jingsong</creator><creator>Chang, Guangqi</creator><creator>Huang, Yonghui</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202111</creationdate><title>The earlier, the better: The beneficial effect of different timepoints of the preoperative transarterial embolization on ameliorating operative blood loss and operative time for carotid body tumors</title><author>Li, Nan ; Zeng, Ni ; Wan, Yuan ; Wen, Chunyong ; Yang, Jianyong ; Li, Jiaping ; Dai, Haitao ; Liao, Changli ; Tang, Keyu ; Wang, Jingsong ; Chang, Guangqi ; Huang, Yonghui</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-e6aa824fc708535f678c49308c5e65f4218689b0585fd475a89404cc86a5de833</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Blood Loss, Surgical - prevention & control</topic><topic>Carotid Body Tumor - surgery</topic><topic>Child</topic><topic>Embolization, Therapeutic</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Operative Time</topic><topic>Preoperative Care</topic><topic>Retrospective Studies</topic><topic>Time Factors</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Nan</creatorcontrib><creatorcontrib>Zeng, Ni</creatorcontrib><creatorcontrib>Wan, Yuan</creatorcontrib><creatorcontrib>Wen, Chunyong</creatorcontrib><creatorcontrib>Yang, Jianyong</creatorcontrib><creatorcontrib>Li, Jiaping</creatorcontrib><creatorcontrib>Dai, Haitao</creatorcontrib><creatorcontrib>Liao, Changli</creatorcontrib><creatorcontrib>Tang, Keyu</creatorcontrib><creatorcontrib>Wang, Jingsong</creatorcontrib><creatorcontrib>Chang, Guangqi</creatorcontrib><creatorcontrib>Huang, Yonghui</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Nan</au><au>Zeng, Ni</au><au>Wan, Yuan</au><au>Wen, Chunyong</au><au>Yang, Jianyong</au><au>Li, Jiaping</au><au>Dai, Haitao</au><au>Liao, Changli</au><au>Tang, Keyu</au><au>Wang, Jingsong</au><au>Chang, Guangqi</au><au>Huang, Yonghui</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The earlier, the better: The beneficial effect of different timepoints of the preoperative transarterial embolization on ameliorating operative blood loss and operative time for carotid body tumors</atitle><jtitle>Surgery</jtitle><addtitle>Surgery</addtitle><date>2021-11</date><risdate>2021</risdate><volume>170</volume><issue>5</issue><spage>1581</spage><epage>1585</epage><pages>1581-1585</pages><issn>0039-6060</issn><eissn>1532-7361</eissn><abstract>To explore the effect of the optimal time interval from preoperative transarterial embolization to surgery of carotid body tumors by analyzing surgery-related indicators.
This single-center retrospective review included 103 patients and 108 carotid body tumor resections performed between June 2010 and June 2020. All carotid body tumors were divided into three groups based on interval time between transarterial embolization and surgery: 1-day group (G1), 2-day group (G2), and 3-day group (G3). Demographics, inflammatory biomarkers, periprocedural details, and postoperative outcomes were analyzed.
Among 103 patients, 48.54% were women, and the mean age was 37.07 years. The tumor sizes were 43.83, 44.31, and 42.84 mm in G1, G2, and G3, respectively, and the blood loss and operative time were 163.68, 331.54, and 683.68 mL, and 182.32, 216.31, and 280.79 mins with the prolonged time interval, respectively. Compared with pretransarterial embolization, the expression of white blood cells (109/L) and neutrophils (109/L) were obviously increased post-transarterial embolization in the three groups (G1: white blood cells 6.81 vs 9.32; neutrophils 0.54 vs 0.74, all P < .05. G2: white blood cells 7.19 vs 10.01, P = .118; neutrophils 0.54 vs 0.77, P < .05. G3: white blood cells 7.08 v. 12.37; neutrophils 0.59 vs 0.80, all P < .05), and those in G3 were significantly higher than those in G1. The incidences of revascularization, which was 30.26%, 53.85%, and 42.10%, and adverse events (26.32%, 30.77%, and 21.05%) were not significantly different among G1, G2, and G3.
The optimal time interval between preoperative transarterial embolization and surgical resection resulted as 1 day as patients in this group showed obvious lower blood loss and shorter duration of operation than patients in other groups. Both inflammation and recanalization provided support for these results at some extent.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>34376306</pmid><doi>10.1016/j.surg.2021.07.005</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0039-6060 |
| ispartof | Surgery, 2021-11, Vol.170 (5), p.1581-1585 |
| issn | 0039-6060 1532-7361 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2560297467 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Adolescent Adult Blood Loss, Surgical - prevention & control Carotid Body Tumor - surgery Child Embolization, Therapeutic Female Humans Male Middle Aged Operative Time Preoperative Care Retrospective Studies Time Factors Young Adult |
| title | The earlier, the better: The beneficial effect of different timepoints of the preoperative transarterial embolization on ameliorating operative blood loss and operative time for carotid body tumors |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T15%3A20%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20earlier,%20the%20better:%20The%20beneficial%20effect%20of%20different%20timepoints%20of%20the%20preoperative%20transarterial%20embolization%20on%20ameliorating%20operative%20blood%20loss%20and%20operative%20time%20for%20carotid%20body%20tumors&rft.jtitle=Surgery&rft.au=Li,%20Nan&rft.date=2021-11&rft.volume=170&rft.issue=5&rft.spage=1581&rft.epage=1585&rft.pages=1581-1585&rft.issn=0039-6060&rft.eissn=1532-7361&rft_id=info:doi/10.1016/j.surg.2021.07.005&rft_dat=%3Cproquest_cross%3E2560297467%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2560297467&rft_id=info:pmid/34376306&rft_els_id=S0039606021006887&rfr_iscdi=true |